Table 5.
Model 1 | Model 2 | Model 3 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
β | se | p | CI (95%) | β | se | p | CI (95%) | β | se | p | CI (95%) | ||||
Intercept | −248.402 | 100.597 | 0.014 | −445.5 | −51.23 | 48.384 | 76.752 | 0.528 | −102.04 | 198.81 | 15.745 | 10.597 | 0.137 | −5.02 | 36.51 |
NEP | −14.763 | 1.516 | 0.000 | −17.73 | −11.79 | 2.161 | 1.421 | 0.128 | −0.62 | 4.94 | −0.714 | 0.308 | 0.020 | −1.31 | −0.11 |
PAm | −4.019 | 4.658 | 0.388 | −13.14 | 5.11 | 0.447 | 2.783 | 0.873 | −5.00 | 5.90 | 0.222 | 0.426 | 0.601 | −0.61 | 1.05 |
PAv | −5.708 | 5.000 | 0.254 | −15.50 | 4.09 | −4.286 | 2.983 | 0.151 | −10.13 | 1.56 | 0.115 | 0.453 | 0.800 | −0.77 | 1.00 |
Gender M | 1.176 | 4.854 | 0.809 | −8.33 | 10.69 | −9.791 | 2.864 | 0.001 | −15.40 | −4.17 | −0.184 | 0.474 | 0.698 | −1.11 | 0.74 |
Age | −1.189 | 1.786 | 0.506 | −4.68 | 2.31 | −0.386 | 1.071 | 0.719 | −2.48 | 1.71 | 0.003 | 0.161 | 0.986 | −0.31 | 0.31 |
Weight | −1.356 | 0.718 | 0.059 | −2.76 | 0.05 | 0.224 | 0.593 | 0.706 | −0.93 | 1.38 | 0.148 | 0.079 | 0.060 | −0.00 | 0.30 |
Height | 1.441 | 0.585 | 0.014 | 0.29 | 2.58 | −0.116 | 0.456 | 0.799 | −1.01 | 0.77 | −0.094 | 0.062 | 0.127 | −0.21 | 0.02 |
BMI | 5.216 | 2.120 | 0.014 | 1.06 | 9.37 | −0.123 | 1.707 | 0.943 | −3.46 | 3.22 | −0.287 | 0.233 | 0.217 | −0.74 | 0.16 |
PhA | 4.680 | 1.692 | 0.006 | 1.36 | 7.99 | −1.663 | 1.354 | 0.219 | −4.31 | 0.99 | −0.163 | 0.218 | 0.454 | −0.58 | 0.26 |
Model 1: Ferritin vs. NEP, PA, Gender, Age, Weight, Height, BMI, PhA. Model 2: ESR vs. NEP, PA, Gender, Age, Weight, Height, BMI, PhA. Model 3: CRP vs. NEP, PA, Gender, Age, Weight, Height, BMI, PhA. PAm, moderate physical activity; PAv, vigorous physical activity. CI, confidence interval; The regression coefficient (β), the standard error (se), and the statistical significance (p) are reported. The p-value was adjusted with the Holm–Šidák method (extension of Holm–Bonferroni method). In boldface are reported statistically significant values.